跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Sevorane
Approved
STANDARD
Sevorane
AbbVie S.r.L.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4ded7fcf9d96fe21
Company
AbbVie S.r.L.
Type
Standard
Approval Details
Approval Id
4ded7fcf9d96fe21
Drug Approval Philippines Name
Sevorane
Product Name
Sevorane
Registration Number
DR-XY31826
Brand Name
Sevorane
Generic Name
Sevoflurane
Dosage Form
Liquid for Inhalation
Dosage Strength
1
Manufacturer
AbbVie S.r.L.
Company Detail Path
/organization/abbvie-srl
Issuance Date
18 August 2023
Expiry Date
15 November 2028
Pharmacologic Category
General Anesthetic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4ded7fcf9d96fe21
Type
Standard
Back to Philippines FDA Approvals
Sevorane - Philippines FDA Drug Approval Details